Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
2024 Watch Gathering: The Best Watches of the Year - 2Dr. Vinay Prasad's memo raises concerns about COVID-19 vaccines and pediatric mortality
- 3The Significance of Prenuptial Arrangements in Separation Procedures
- 4Spots to Go Hang Floating
- 51st-ever disease gene fix, Alzheimer's blood test: 7 medical breakthroughs in 2025
- NATO needs Ukraine's 'adaptation DNA' and an 'HOV lane' for new war tech, top commander says
- Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up
- Ariana Grande to host 'Saturday Night Live' Christmas show with Cher as musical guest, returning after nearly 40 years
- Most loved Road Food: Which One Prevails upon You?
- Lift Your Style: Famous Hairdos for Ladies
- Germany's first Omani LNG shipments arrive despite Middle East disruptions
- After toilet and email issues, Artemis II astronauts fire engine to head for the moon
- Coffee Prices Finish Higher on Brazil Cop Concerns
- Picking the Right Home Machines: A Commonsense Aide
